Home › Research › Topics › predictors
predictors
5 studies tagged predictors, dated 2004-07-01 to 2025-01-09. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease 2025-01-09
- Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia 2022-12-09
- CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design 2022-02-28
Studies
5 studies carry this tag.
Date range
2004 to 2025
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Experimental gerontology 1
- Fluids and barriers of the CNS 1
- Molecular psychiatry 1
- PloS one 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.
-
The results of this study suggest that homocysteine levels are independently associated with impaired cognitive function and increased five-year mortality.
-
Clinical trials testing tau-targeting therapies may benefit from using fluid biomarkers to recruit individuals at risk of tau aggregation.
-
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of major interest in AD research.
-
Subjects with mild cognitive impairment (MCI) are at a high risk of developing clinical Alzheimer's disease (AD).